2023年1月〜

原著論文

1. Identifying the Carcinogenic Mechanism of Malignant Struma Ovarii Using Whole-Exome Sequencing and DNA Methylation Analysis.
Yamashita H, Nakayama K, Kanno K, Ishibashi T, Ishikawa M, Sato S, Iida K, Razia S, Kyo S.  
Curr Issues Mol Biol. 2023 Feb 23;45(3):1843-1851. doi: 10.3390/cimb45030118. PMID: 36975488; PMCID: PMC10047136.

2. Androgen promotes squamous differentiation of atypical cells in cervical intraepithelial neoplasia via an ELF3-dependent pathway. 
Matsumoto T, Suzuki T, Nakamura M, Yamamoto M, Iizuka T, Ono M, Kagami K, Kasama H, Kanda T, Sakai Y, Iwadare J, Matsuoka A, Kayahashi K, Wakae K, Muramatsu M, Kyo S, Yamamoto Y, Mizumoto Y, Daikoku T, Fujiwara H.  
Cancer Med. 2023 Mar 23. doi: 10.1002/cam4.5824. Epub ahead of print. PMID: 36951594.
CopyDownload .nbib

3. Kisspeptin induces Kiss-1 and GnRH gene expression in mHypoA-55 hypothalamic cell models: Involvement of the ERK and PKA signaling pathways.
Tumurbaatar T, Kanasaki H, Yacca SS, Cairang Z, Tumurgan Z, Oride A, Okada H, Kyo S.
Gen Comp Endocrinol. 2023 Mar 16;337:114260. doi: 10.1016/j.ygcen.2023.114260. Epub ahead of print. PMID: 36933747.

4. Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation.
Sato S, Nakayama K, Kanno K, Sultana R, Ishikawa M, Ishibashi T, Yamashita H, Kyo S. 
Cancer Sci. 2023 Feb 26. doi: 10.1111/cas.15767. Epub ahead of print. PMID: 36843384.

5. Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status.
Sawada K, Nakayama K, Razia S, Yamashita H, Ishibashi T, Ishikawa M, Kanno K, Sato S, Nakayama S, Otsuki Y, Kyo S.
Healthcare (Basel). 2023 Apr 9;11(8):1073. doi: 10.3390/healthcare11081073.

6. Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study.
Razia S, Nakayama K, Yamashita H, Ishibashi T, Ishikawa M, Kanno K, Sato S, Kyo S.
Curr Oncol. 2023 Apr 4;30(4):4052-4059. doi: 10.3390/curroncol30040307.

7. The Case of an Endometrial Cancer Patient with Breast Cancer Who Has Achieved Long-Term Survival via Letrozole Monotherapy. 
Ishikawa M, Nakayama K, Razia S, Yamashita H, Ishibashi T, Haraga H, Kanno K, Ishikawa N, Kyo S.
Curr Issues Mol Biol. 2023 Apr 1;45(4):2908-2916. doi: 10.3390/cimb45040190.

8. Fusobacterium infection facilitates the development of endometriosis through the phenotypic transition of endometrial fibroblasts. 
Muraoka A, Suzuki M, Hamaguchi T, Watanabe S, Iijima K, Murofushi Y, Shinjo K, Osuka S, Hariyama Y, Ito M, Ohno K, Kiyono T, Kyo S, Iwase A, Kikkawa F, Kajiyama H, Kondo Y.
Sci Transl Med. 2023 Jun 14;15(700):eadd1531. doi: 10.1126/scitranslmed.add1531. Epub 2023 Jun 14.

9. Integrative analysis reveals early epigenetic alterations in high-grade serous ovarian carcinomas.
Machino H, Dozen A, Konaka M, Komatsu M, Nakamura K, Ikawa N, Shozu K, Asada K, Kaneko S, Yoshida H, Kato T, Nakayama K, Saloura V, Kyo S, Hamamoto R.
Exp Mol Med. 2023 Oct 2. doi: 10.1038/s12276-023-01090-1.

10. Changes in pituitary gonadotropin subunits and hypothalamic Kiss-1 gene expression by administration of sex steroids in ovary-intact female rats. Endocrine.
Yacca SS, Kanasaki H, Tumurbaatar T, Cairang Z, Oride A, Okada H, Kyo S. 
Endocrine. 2023 Nov 15. doi: 10.1007/s12020-023-03596-0. 

このページのトップへ